Pharmacodynamics Mianserin




mianserin antagonist/inverse agonist (at or sites) of histamine h1 receptor, serotonin 5-ht1d, 5-ht1f, 5-ht2a, 5-ht2b, 5-ht2c, 5-ht3, 5-ht6, , 5-ht7 receptors, , α1- , α2-adrenergic receptors, , inhibits reuptake of norepinephrine well. h1 receptor inverse agonist high affinity, mianserin has strong antihistamine effects (e.g., sedation). conversely, has low affinity muscarinic acetylcholine receptors, , hence lacks anticholinergic properties. mianserin has been found low affinity potentially significant partial agonist of κ-opioid receptor (ki = 1.7 μm; ec50 = 0.53 μm), tricyclic antidepressants (tcas).


blockade of h1 , possibly α1-adrenergic receptors has sedative effects, , antagonism of 5-ht2a , α1-adrenergic receptors inhibits activation of intracellular phospholipase c (plc), seems common target several different classes of antidepressants. antagonizing somatodendritic , presynaptic α2-adrenergic receptors function predominantly inhibitory autoreceptors , heteroreceptors, mianserin disinhibits release of norepinephrine, dopamine, serotonin, , acetylcholine in various areas of brain , body.


along mirtazapine, although lesser extent in comparison, mianserin has been described noradrenergic , specific serotonergic antidepressant (nassa). however, actual evidence in support of label has been regarded poor.








Comments

Popular posts from this blog

Mobility.2C training and insignia Impi

Expenses controversy Ian Gibson (politician)

11th century parish church of St Leonard Hythe, Kent